Pluslife Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10.9M
- Investors
-
5
Pluslife General Information
Description
Developer of a molecular diagnostics ecosystem intended for patient testing for human and veterinary health. The company offers portable assay devices, nucleic acid testing workflows, consumable test cards, integrated operating software, and data management capabilities that support use in clinics, community sites, and laboratories, enabling healthcare providers and public health programs to operate in resource-constrained settings and improve continuity of care across diverse environments.
Contact Information
Website
www.pluslife.comCorporate Office
- 3rd Floor, Block E, Runhui Science and Technology Park
- Number 18 Shenzhou Road, Huangpu District
- Guangzhou, Guangdong
- China
Corporate Office
- 3rd Floor, Block E, Runhui Science and Technology Park
- Number 18 Shenzhou Road, Huangpu District
- Guangzhou, Guangdong
- China
Pluslife Timeline
Pluslife Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 21-Oct-2025 | $10.9M | Completed | Generating Revenue | ||
| 6. Secondary Transaction - Private | 14-Nov-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A1) | 21-Oct-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 01-Sep-2021 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 31-Aug-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 04-Dec-2018 | Completed | Generating Revenue | |||
| 1. Seed Round | 09-May-2018 | Completed | Startup |
Pluslife Patents
Pluslife Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021376720-A1 | Combination product for dna detection | Inactive | 08-Feb-2021 | ||
| EP-4067501-A1 | Combined product for testing dna | Active | 08-Feb-2021 | ||
| EP-4067501-A4 | Combined product for testing dna | Active | 08-Feb-2021 | ||
| EP-4067501-B1 | Combined product for testing dna | Active | 08-Feb-2021 | ||
| EP-4067501-C0 | Combined product for testing dna | Active | 08-Feb-2021 | C12Q1/6844 |
Pluslife Signals
Pluslife Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Guangzhou Hi-tech Investment Group | Government | Minority | ||
| Shanghai Fengcang Equity Investment Fund Management | Growth/Expansion | Minority | ||
| Puhua Capital | Venture Capital | Minority | ||
| Qiming Venture Partners | Venture Capital | Minority | ||
| Star River Group | Corporation | Minority |
Pluslife FAQs
-
When was Pluslife founded?
Pluslife was founded in 2017.
-
Where is Pluslife headquartered?
Pluslife is headquartered in Guangzhou, China.
-
What is the size of Pluslife?
Pluslife has 12 total employees.
-
What industry is Pluslife in?
Pluslife’s primary industry is Diagnostic Equipment.
-
Is Pluslife a private or public company?
Pluslife is a Private company.
-
What is Pluslife’s current revenue?
The current revenue for Pluslife is .
-
How much funding has Pluslife raised over time?
Pluslife has raised $37.1M.
-
Who are Pluslife’s investors?
Guangzhou Hi-tech Investment Group, Shanghai Fengcang Equity Investment Fund Management, Puhua Capital, Qiming Venture Partners, and Star River Group have invested in Pluslife.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process